Introduction For decades, the Indian pharmaceutical industry has measured success using familiar, volume-driven metrics: prescriptions generated, market share gained, sales force productivity, doctor coverage, and quarterly revenue growth. Yet, one critical stakeholder has remained largely absent from this commercial equation—the patient. This omission is rapidly becoming a significant strategic vulnerability. As India’s disease burden shifts…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
